Assessing Prognosis in Patients with Lower-Risk Myelodysplastic Syndromes. Parameters Related to the Probability of Leukemic Progression
Falantes, J.F, Márquez-Malaver, F.J, Calderón-Cabrera, C, Martino, M.L, Isabel, M, Jose, G, Espigado, I, Pérez-Simón, J.A
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome
Rodríguez-Arbolí, E, Morales-Camacho, R, Prats-Martín, C, Carrillo, E, Vargas, M.T, Caballero-Velázquez, T, Montero, I, Falantes, J.F, Pérez-López, O, de Blas, J.M, Verdesoto-Cozzarelli, S, Bernal, R, Pérez-Simón, J.A
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Role of Second Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Hematologic Malignancies
Falantes, J.F, Carrillo, E, Márquez, F, Carmona, M, Espigado, I
Published in Transplantation proceedings (01.10.2010)
Published in Transplantation proceedings (01.10.2010)
Get full text
Journal Article
Conference Proceeding
P-132 Higher-risk myelodysplastic syndromes. Does the severity of cytopenias at diagnosis have any prognostic significance?
Calderón, C, Falantes, J.F, Márquez, F.J, Martino, M.L, González, J, Montero, M.I, Parody, R, Espigado, I, Pérez-Simón, J.A
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS
Campelo, M. Diez, Lorenzo, J.I, Benlloch, L, Lopez-Pavia, M, Such, E, Bernal, T, Luño, E, Davila, J, Ramos, F, Calabuig, M, Pomares, H, Gonzalez, B, Merchan, B, Barranco, E, Tello, R. Sancho, Callejas, M, Requena, M.J, Jimenez, M.J, Pedreño, M, Vicente, A.I, Medina, A, Campeny, A, Sansa, M. Cortes, Pedro, C, Falantes, J.F, Arilla, M.J, Barez, A, Garcia, R, Arcos, M.J, Gomez, V, Muñoz, C, Cervero, C, Casaño, J, de Paz, R, Amigo, L, Insunza, A, Muñoz, J.A, Cedena, M.T, Gomez, M, Font, P, del Campo, R, Lago, C. Fernandez, Hurtado, J.A. Gonzalez, Latorre, M.D. Linares, Casado, A. Mora, Vahi, M, Sanz, G.F, Cañizo, M.C
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
244 - Assessing Prognosis in Patients with Lower-Risk Myelodysplastic Syndromes. Parameters Related to the Probability of Leukemic Progression
Falantes, J.F., Márquez-Malaver, F.J., Calderón-Cabrera, C., Martino, M.L., Isabel, M., Jose, G., Espigado, I., Pérez-Simón, J.A.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
PB2215 HOW TO PREDICT RESPONSE TO RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS
Montero, M.I., Reinoso, M., Pérez‐Ortega, L., Márquez, F.J., Rodríguez‐Arbolí, E., Rodríguez, N., Falantes, J.F., Espigado, I., Pérez‐Simón, J.A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
127 - Extreme Granulocytic Dysplasia in a De Novo Myelodysplastic Syndrome
Rodríguez-Arbolí, E., Morales-Camacho, R., Prats-Martín, C., Carrillo, E., Vargas, M.T., Caballero-Velázquez, T., Montero, I., Falantes, J.F., Pérez-López, O., de Blas, J.M., Verdesoto-Cozzarelli, S., Bernal, R., Pérez-Simón, J.A.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
PF216 ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA‐FLUGAZA PHASE III CLINICAL TRIAL
Paiva, B., Martínez‐Cuadrón, D., Bergua, J.M., Vives, S., Algarra, L., Tormo, M., Martinez, P., Serrano, J., Herrera, P., Ramos, F., Salamero, O., Lavilla, E., Gil, C., Lopez, J.L., Vidriales, M.B., Labrador, J., Falantes, J.F., Sayas, M.J., Merino, J., Alfonso, A., Prosper, F., San Miguel, J., Sanz, M.A., Montesinos, P.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY
Seymour, J.F, Döhner, H, Butrym, A, Wierzbowska, A, Selleslag, D, Jang, J.H, Cavenagh, J.D, Kumar, R, Schuh, A.C, Candoni, A, Récher, C, Sandhu, I, del Castillo, T. Bernal, Al-Ali, H.K, Martinelli, G, Falantes, J, Nopenney, R, Stone, R.M, Minden, M.D, McIntyre, H, Songer, S, Lucy, L.M, Beach, C.L, Dombret, H
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY
Döhner, H, Seymour, J.F, Butrym, A, Wierzbowska, A, Selleslag, D, Jang, J.H, Cavenagh, J.D, Kumar, R, Schuh, A.C, Candoni, A, Récher, C, Sandhu, I, del Castillo, T. Bernal, Al-Ali, H.K, Martinelli, G, Falantes, J, Nopenney, R, Stone, R.M, Minden, M.D, McIntyre, H, Songer, S, Lucy, L.M, Beach, C.L, Dombret, H
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article